Results 301 to 310 of about 119,230 (327)
Some of the next articles are maybe not open access.

Restenosis: a challenge for pharmacology

Trends in Pharmacological Sciences, 2000
The quest for an anti-restenotic drug continues to be a major challenge in the field of cardiovascular pharmacology because most therapies with proven efficacy in experimental neointima models have failed to limit restenosis. Some drug classes, including glycoprotein IIb/IIIa antagonists, nitric oxide donors and the antioxidant probucol, have recently ...
openaire   +4 more sources

Mechanisms of drug-eluting stent restenosis

Cardiovascular Intervention and Therapeutics, 2020
J. Aoki, K. Tanabe
semanticscholar   +1 more source

Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty.

New England Journal of Medicine, 1987
U. Sigwart   +4 more
semanticscholar   +1 more source

Restenosis and in-stent restenosis

2008
David J. Moliterno, Nezar M. Falluji
openaire   +2 more sources

Therapeutic Options for In-Stent Restenosis

Current Cardiology Reports, 2018
C. Nicolais   +6 more
semanticscholar   +1 more source

Restenosis

Coronary Artery Disease, 1993
David R. Holmes, Robert S. Schwartz
openaire   +3 more sources

Percutaneous coronary interventional strategies for treatment of in-stent restenosis: a network meta-analysis

The Lancet, 2015
G. Siontis   +11 more
semanticscholar   +1 more source

Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study.

Circulation, 1996
Rainer Hoffmann   +8 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy